AI 导读
OpenAI 宣布收购 Orchestra Bio，一个帮助生物制药团队协调药物开发复杂流程的平台。双方将基于 Rosalind 与 OpenAI 的 AI 模型和工具整合，简化药物研发运营，帮助新疗法更快惠及患者。
正文
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
https://openai.com/index/openai-to-acquire-orchestra-bio/
来源：OpenAI · x.com